ENTRY       D12124                      Drug
NAME        Lilotomab (USAN/INN)
FORMULA     C6442H9862N1696O2028S54
EXACT_MASS  145156.5627
MOL_WEIGHT  145246.8901
SEQUENCE    (Heavy chain)
            EIQLQQSGPE LVKPGASVKV SCKASGYSFT DYNMYWVKQS HGKSLEWIGY IDPYNGDTTY
            NQKFKGKATL TVDKSSSTAF IHLNSLTSED SAVYYCARSP YGHYAMDYWG QGTSVTVSSA
            KTTPPSVYPL APGSAAQTNS MVTLGCLVKG YFPEPVTVTW NSGSLSSGVH TFPAVLQSDL
            YTLSSSVTVP SSTWPSETVT CNVAHPASST KVDKKIVPRD CGCKPCICTV PEVSSVFIFP
            PKPKDVLTIT LTPKVTCVVV DISKDDPEVQ FSWFVDDVEV HTAQTQPREE QFNSTFRSVS
            ELPIMHQDWL NGKEFKCRVN SAAFPAPIEK TISKTKGRPK APQVYTIPPP KEQMAKDKVS
            LTCMITDFFP EDITVEWQWN GQPAENYKNT QPIMDTDGSY FVYSKLNVQK SNWEAGNTFT
            	CSVLHEGLHN HHTEKSLSHS PGK
            (Light chain)
            DIVMTQSHKL LSTSVGDRVS ITCKASQDVS TAVDWYQQKP GQSPKLLINW ASTRHTGVPD
            RFTGSGSGTD YTLTISSMQA EDLALYYCRQ HYSTPFTFGS GTKLEIKRAD AAPTVSIFPP
            SSEQLTSGGA SVVCFLNNFY PKDINVKWKI DGSERQNGVL NSWTDQDSKD STYSMSSTLT
            LTKDEYERHN SYTCEATHKT STSPIVKSFN RNEC
            (Disulfide bridge: H22-H96, H146-H201, H221-L214, H223-H'223, H226-H'226, H228-H'228, H257-H317, H363-H421, H'22-H'96, H'146-H'201, H'221-L'214, H'257-H'317, H'363-H'421, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody
TARGET      CD37 [HSA:951] [KO:K06475]
  PATHWAY   hsa04640(951)  Hematopoietic cell lineage
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD37
                 D12124  Lilotomab (USAN/INN)
DBLINKS     CAS: 1453362-55-4
///
